The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.
2019 Prizes and AwardsView photos, reflections and biographies from this year's prize winners. Continually updated, so check back often.
Pocket Prescriber PsychiatryThe new Pocket Prescriber Psychiatry book is out now.
Visualising Psychotropic Medicine (VPM)Presenting what can be a complex set of data in a useful and engaging way
Online CPD ResourceRCPsych Online CPD Subscribers get a discount on the BAP Online Resource
Fundamentals of Clinical PsychopharmacologyBuy a discounted copy of the latest edition of Fundamentals of Clinical Psychopharmacology
The Ten Secrets of Success in ScienceView Professor Trevor Robbins presenting his top tips
Neuroscience-based Nomenclature (NbN) for JoPJournal of Psychopharmacology chosen to trial new NbN
Fundamentals Wins BMA AwardFundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Not all in the mind – the contribution of brain science to modern psychiatryWatch Prof David Nutt's lecture in Manchester on YouTube
Benefits of BAP membership include:
- FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
- Reduced registration fees for the annual Summer Meeting.
- Half price subscription to the Online CPD Resource.
- Eligibility for prizes and awards.
- Student bursaries for the BAP Summer Meeting and international conferences.
- Reduced registration fees for selected partner association events.
- 50% OFF Royal Society of Biology membership (Read more)
- BAP Newsletter.
- Voting for BAP Officers and Council (full members only).
- Being part of one of the largest national psychopharmacology associations in the world.
|7th September 2019||32nd ECNP Congress||Copenhagen|
|10th September 2019||IoPPN 19th Maudlsey Forum 2019||King’s College London|
|12th September 2019||Drug Treatments in Affective Disorders||The International Centre for Life (Conferences), Newcastle upon Tyne|
Symposium 8 – The orexinergic system of the brain and its importance for neuropsychiatry
By Kristi Sawyer
Posted on 20th July 2019
Chaired by: Professor Elemer Szabadi (Nottingham) Professor Jyrki Kukkonen (Helsinki): Neuroanatomy and physiology of the orexinergic system. Professor Kukkonen kicked-off this session on Wednesday morning by giving us a comprehensive overview of the orexinergic system. We learned that orexins were discovered by 2 groups independently, within weeks of each other, around 20 years ago, in […]
Psychopharmacology Awards – Winners’ Short Orals
By Alexandra Pike
Posted on 19th July 2019
This session, in which winners of the Psychopharmacology Awards present their work, always has high attendance and this year was no exception. Dr Tom Freeman, the winner of the junior non-clinical award, presented on the role of cannabinoids in the development and treatment of addiction. He noted that recent policy changes in the UK have […]
Symposium 7 – What do computational models tell us about cognition in depression and psychosis?
By Ellie Smith
Posted on 19th July 2019
This symposium discussed how computational models could be used to explore decision-making and prediction learning in psychiatric disorders. By including computational modelling in our analyses we can identify and quantify key parameters, which are not visible to traditional analyses, and can often be successfully linked to the function of underlying neural systems or to clinically […]
MQ Open Mind Podcast
Helen Fisher and MQ ambassador John discuss risk for developing depression and the Identifying Depression Early in Adolescence (IDEA) Project.
29th July 2019
Understanding the infant-parent connection: summary interview
Barbara Sahakian interviews developmental cognitive neuroscientist Dr Victoria Leong about her research with mothers and babies exploring how they naturally synchronise during social interactions, helping babies learn from their mothers.
26th July 2019
Is excessive use of social media an addiction?
International COST Action CA16207 is a research focussed network on problematic internet addiction. Covered by ABC News
3rd May 2019
Psychedelics, addiction, and mental health
David talks to ABC Radio National about psychedelics, addiction, and mental health
24th February 2019
Hollywood past saves climber Hamish MacInnes from dementia death sentence
Stephen was quoted in the Times article about how Hamish MacInnes recovered from Dementia with the help of his films and books
22nd February 2019
|2019 Prizes and Awards |
25th July 2019
View all award winners from this year's meeting. Photos, reflections and biographies are being continually updated, so check back often.
View this year's prize winners
|Street Drugs Conference Wales 2019: Is the Dragon Still Smoking? |
13th July 2019
Overview of the latest Street Drugs Conference in Wales on 25th June.
Read the review
|REF2021 Success |
4th February 2019
Prof Allan Young, Prof Jeremy Hall and Prof Helen Cassaday selected to join REF2021 panel 4: Psychology, Psychiatry and Neuroscience
|Professor David Nutt Wins Academic Honorary Award in Istanbul |
9th November 2018
Professor David Nutt has won the Academic Honorary Award at the International Crime and Punishment Film Festival in Istanbul
Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.